The Pest Control Landscape in 2026: The Burden of Proof Has Moved
No single invention reshaped commercial pest management. What changed is the standard of justification a programme is now expected to meet.
For years the service model was straightforward. A technician attended at fixed intervals, inspected a familiar circuit of monitoring points, treated where required and left a report. Contracts were compared on visit frequency, response time and annual price, because those were the variables a buyer could see.
That model has not disappeared, and not every established method deserves discarding because something now arrives with a dashboard. But across 2025 and into 2026, a sequence of separate developments has quietly converged on the same requirement. Chemical controls came under closer scrutiny. Resistance data continued to undermine habitual treatment choices. Remote monitoring settled into a defined role. Animal-welfare legislation narrowed the methods available. Certification requirements tightened. Audit schemes revised their expectations.
None of these was coordinated. Taken together they describe one change: the shift from a service judged by what it does to a service judged by what it can justify.
Rodenticide became a decision rather than a routine
Rodenticides remain necessary professional tools. Rodents present real risks to public health, food safety, property and infrastructure, and there are circumstances in which chemical control is both appropriate and unavoidable.
What changed is the burden of justification attached to reaching for one.
From January 2025, the option to use second-generation anticoagulant rodenticides in designated open areas and waste dumps was removed. CRRU UK subsequently revised its guidance on permanent baiting, and the Health and Safety Executive has consulted on the availability of lower-risk alternatives as part of the renewal assessment for anticoagulant products. HSE guidance is explicit that non-chemical methods, prevention and lower-risk options should be considered before anticoagulant products are selected.
The significance sits in the principle rather than any individual restriction. Anticoagulants are being retained because effective rodent control matters, while the risks they carry to people, wildlife and the environment are being met with tighter conditions on their use.
Placing rodenticide because a monitoring point has always contained rodenticide is no longer a defensible rationale. A competent programme has to explain why the product is needed, why it suits that location, how long it will remain deployed, what environmental risks were weighed, and what would justify removing it.
The distinction is quiet but consequential. Treatment has become a decision requiring evidence, not a routine that renews itself.
Resistance made diagnosis more valuable than familiarity
Resistance is not a new subject in rodent management. What recent monitoring reinforces is the risk of treating every failure as a request for more of the same.
CRRU UK's 2025 resistance report recorded anticoagulant-resistance mutations in 106 of the 122 Norway rat samples analysed during the reporting period, and reported that 94.4 per cent of house-mouse samples successfully sequenced since the monitoring series began carried a resistance mutation. These are submitted samples rather than a representative national prevalence survey, and the report notes that sample volumes fell below the intended target. They evidence a serious and geographically variable problem. They are not a percentage applicable to every infestation in Britain.
The operational lesson is less qualified than the data.
Where control fails, the answer cannot automatically be a longer treatment period or a more familiar active substance. Building defects, competing food sources, behavioural avoidance, immigration from neighbouring land and physiological resistance can all produce results that look identical on a service sheet. They require entirely different responses.
The technician's value therefore concentrates in diagnosis: interpreting activity, reading the site, testing assumptions and revising the programme accordingly.
A bait box is a container. The judgement is the service.
Method restriction is now a legal boundary, not a preference
The retreat from rodent glue boards has continued to narrow the options available.
In England, using a glue trap to catch a rodent is unlawful unless carried out by a qualified professional under licence in defined circumstances. Wales prohibits their use outright. In Scotland, the position changed materially this summer: since 1 July 2026, under the Wildlife Management and Muirburn (Scotland) Act 2024, it has been a criminal offence to use, supply or possess a glue trap. On summary conviction the penalty extends to twelve months' imprisonment or a fine of up to £40,000, and on conviction on indictment to five years or an unlimited fine. Commencement had been delayed because the Internal Market Act 2020 prevented Scotland restricting sale until the UK Government made an exclusion for glue traps, which came into force in February 2026.
For commercial clients this reaches beyond compliance. Some high-risk environments historically treated glue boards as a last safeguard, particularly where toxic treatment was undesirable. Removing that option requires more than substituting one device for another. It requires stronger exclusion, better environmental control, more discriminating monitoring and faster escalation, all specified before an emergency rather than improvised during one.
Stratton removed rodent glue boards from its operating model and invested instead in mechanical capture, non-toxic detection and exclusion-led control. That was not a display of virtue. A method exposed to restriction, welfare objection and operational misuse makes a poor foundation for a programme intended to last.
Competence and evidence both became demonstrable
From 1 January 2026, professional users purchasing stewardship-labelled rodenticides have had to provide evidence of recent CRRU-approved training, or combine an older approved qualification with membership of a recognised continuing professional development scheme. Farm-assurance membership alone no longer serves as proof of competence.
A certificate does not guarantee a good technician. It does mean informal familiarity with products is no longer sufficient, and that clients in audit-sensitive sectors should expect competence evidence to be available on request rather than retrieved after an uncomfortable exchange with an auditor.
The same movement is visible in what audited sites must now produce. Clients need to know not merely whether activity was found, but where, whether it is recurring, what conditions contributed, what corrective action was assigned and whether that action closed. New issues of all four SALSA standards became available on 1 June 2026, and from 1 September 2026 all SALSA audits will be conducted against them, aligning the scheme with current legislation and buyer expectations.
A service sheet confirms attendance. It cannot demonstrate that a programme is improving. That requires continuity between visits: recommendations tracked, activity trended, site plans kept accurate, and repeated observations triggering investigation rather than reappearing indefinitely beneath a fresh date.
Where Stratton's model sits
Stratton's response has not been to attach fashionable products to a conventional contract.
The operating model begins with SEPOS, the Stratton Environmental Professional Operating Standard: a proprietary internal standard, not an external certification, running research, consultation, design, implementation and review. The sequence is the point. It prevents equipment, pesticides or visit schedules from being selected before the risk has been understood.
Research establishes operational context, pest history, structural vulnerability and external pressure. Consultation brings quality, facilities and operational teams into the process. The programme is designed against that evidence, implemented with defined responsibilities, and reviewed against results.
The model favours non-toxic intervention ahead of rodenticide, prevention ahead of repeated treatment, and investigation ahead of escalation. Rodenticides remain available where the risk assessment justifies them. They are not the default contents of every external station. Monitoring technology is deployed where it improves surveillance or clarifies a picture of activity, not as evidence of innovation. A smart monitor in the wrong position is an expensive object enjoying excellent connectivity.
For SALSA and BRCGS sites, that produces something more useful than a compliant folder. It produces a programme whose reasoning survives examination.
What buyers should expect now
The dividing line is not between traditional and technological providers, nor between those who use pesticides and those who do not.
It runs between providers who can justify their decisions and providers who can only describe their routines.
Clients should expect an explanation of why each control measure exists, how activity is being interpreted, and what conditions are preventing permanent resolution. They should expect monitoring to improve response and insight rather than reduce labour. They should expect proofing recommendations to be prioritised, assigned and reviewed. They should expect chemical use to be proportionate, time-limited and defensible.
They should also expect candour. No credible provider can promise a commercial site will never encounter a pest. Buildings change, deliveries arrive, drainage fails, neighbouring activity creates pressure, and doors are propped open with almost touching faith in the deterrent qualities of a laminated sign.
The professional undertaking is not permanent immunity. It is that risk will be understood, emerging activity detected, intervention kept proportionate, and the programme revised by what occurred.
Cheap, routine and largely unexamined contracts will continue to sell, because they are easy to compare and reassuringly uncomplicated. They will also become progressively harder to defend when activity persists, an auditor starts asking questions, or the treatment record reveals a great deal of motion and very little progress.
This article provides general operational information and does not constitute legal advice. Organisations should confirm the requirements applicable to their activities, products and jurisdiction.